М. А. Дымова

939 total citations
45 papers, 610 citations indexed

About

М. А. Дымова is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, М. А. Дымова has authored 45 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 15 papers in Infectious Diseases and 14 papers in Molecular Biology. Recurrent topics in М. А. Дымова's work include Tuberculosis Research and Epidemiology (15 papers), Mycobacterium research and diagnosis (15 papers) and Virus-based gene therapy research (7 papers). М. А. Дымова is often cited by papers focused on Tuberculosis Research and Epidemiology (15 papers), Mycobacterium research and diagnosis (15 papers) and Virus-based gene therapy research (7 papers). М. А. Дымова collaborates with scholars based in Russia, Ukraine and Kazakhstan. М. А. Дымова's co-authors include Vladimir A. Richter, Elena V. Kuligina, М. Л. Филипенко, S. Yu. Taskaev, Ulan Kozhamkulov, Erlan Ramanculov, Mariya Vorobyeva, A. G. Venyaminova, Д. С. Новопашина and Г. А. Степанов and has published in prestigious journals such as SHILAP Revista de lepidopterología, Advanced Drug Delivery Reviews and International Journal of Molecular Sciences.

In The Last Decade

М. А. Дымова

41 papers receiving 597 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
М. А. Дымова 207 171 152 133 116 45 610
Zbyněk Nový 197 1.0× 95 0.6× 98 0.6× 78 0.6× 39 0.3× 31 484
Ekaterina Revskaya 255 1.2× 188 1.1× 72 0.5× 54 0.4× 24 0.2× 27 610
Shuping Dou 457 2.2× 303 1.8× 70 0.5× 34 0.3× 24 0.2× 47 769
Mark A. Sellmyer 135 0.7× 295 1.7× 89 0.6× 49 0.4× 29 0.3× 35 838
Peicheng Du 85 0.4× 255 1.5× 138 0.9× 149 1.1× 94 0.8× 16 666
Irwin H. Lee 102 0.5× 175 1.0× 35 0.2× 41 0.3× 84 0.7× 8 404
Anna Helbok 221 1.1× 144 0.8× 187 1.2× 121 0.9× 34 0.3× 16 604
Yosuke Harada 81 0.4× 210 1.2× 97 0.6× 54 0.4× 32 0.3× 56 642
Tianyu He 45 0.2× 169 1.0× 158 1.0× 208 1.6× 36 0.3× 52 839
Dragana Jekic-McMullen 109 0.5× 254 1.5× 126 0.8× 40 0.3× 45 0.4× 8 578

Countries citing papers authored by М. А. Дымова

Since Specialization
Citations

This map shows the geographic impact of М. А. Дымова's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by М. А. Дымова with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites М. А. Дымова more than expected).

Fields of papers citing papers by М. А. Дымова

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by М. А. Дымова. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by М. А. Дымова. The network helps show where М. А. Дымова may publish in the future.

Co-authorship network of co-authors of М. А. Дымова

This figure shows the co-authorship network connecting the top 25 collaborators of М. А. Дымова. A scholar is included among the top collaborators of М. А. Дымова based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with М. А. Дымова. М. А. Дымова is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yusubalieva, Gaukhar M., Aleksandra V. Sen’kova, А. В. Ромащенко, et al.. (2025). Efficacy of Oncolytic Virus VV-GMCSF-Lact Against Immunocompetent Glioma. Cells. 14(20). 1619–1619.
2.
Li, Yingying, Tatiana N. Zamay, Л. А. Осминкина, et al.. (2025). Aptamers as a new frontier in targeted cancer therapy. Advanced Drug Delivery Reviews. 226. 115692–115692. 1 indexed citations
3.
Дымова, М. А., et al.. (2024). Using Computer Modeling and Experimental Methods to Screen for Aptamers That Bind to the VV-GMCSF-LACT Virus. Molecules. 29(22). 5424–5424.
4.
Дымова, М. А., et al.. (2024). Cytotoxic effect of the VVGMCSF-Lact oncolytic virus against 3D cultures of human glioblastoma cells U-87 MG. SHILAP Revista de lepidopterología. 8(6). 162–169.
5.
Дымова, М. А., et al.. (2023). Transcriptome Changes in Glioma Cells upon Infection with the Oncolytic Virus VV-GMCSF-Lact. Cells. 12(22). 2616–2616. 1 indexed citations
6.
Wang, Meiling, М. А. Дымова, Ivan Shchudlo, et al.. (2023). Design of the New Closo-Dodecarborate-Containing Gemcitabine Analogue for the Albumin-Based Theranostics Composition. Molecules. 28(6). 2672–2672. 4 indexed citations
7.
Дымова, М. А., et al.. (2022). MicroRNA and mRNA Expression Changes in Glioblastoma Cells Cultivated under Conditions of Neurosphere Formation. Current Issues in Molecular Biology. 44(11). 5294–5311. 3 indexed citations
8.
Kuligina, Elena V., et al.. (2022). Transcriptome Changes in Glioma Cells Cultivated under Conditions of Neurosphere Formation. Cells. 11(19). 3106–3106. 8 indexed citations
9.
Дымова, М. А., Anna S. Kichkailo, Elena V. Kuligina, & Vladimir A. Richter. (2022). Aptamers Enhance Oncolytic Viruses’ Antitumor Efficacy. Pharmaceutics. 15(1). 151–151. 7 indexed citations
10.
11.
Дымова, М. А., et al.. (2021). Modification of a Tumor-Targeting Bacteriophage for Potential Diagnostic Applications. Molecules. 26(21). 6564–6564. 5 indexed citations
12.
Дымова, М. А., et al.. (2020). Boron neutron capture therapy: Current status and future perspectives. Cancer Communications. 40(9). 406–421. 204 indexed citations
13.
Kusliy, Mariya A., Anna S. Druzhkova, Nadezhda V. Vorobieva, et al.. (2018). GENOTYPING AND COAT COLOUR DETECTION OF ANCIENT HORSES FROM BURYATIA.. PubMed. 58(4). 304–8. 2 indexed citations
14.
Дымова, М. А., et al.. (2018). Biological risk factor of occupational morbidity with tuberculosis among medical professionals. Russian Journal of Occupational Health and Industrial Ecology. 52–57. 1 indexed citations
15.
Mokrousov, Igor, et al.. (2018). Early ancient sublineages of Mycobacterium tuberculosis Beijing genotype: unexpected clues from phylogenomics of the pathogen and human history. Clinical Microbiology and Infection. 25(8). 1039.e1–1039.e6. 17 indexed citations
16.
Дымова, М. А., et al.. (2017). GENETIC DIVERSITY OF DRUG RESISTANT STRAINS OF MYCOBACTERIUM TUBERCULOSIS IN OMSK REGION. Tuberculosis and lung diseases. 95(7). 33–39. 1 indexed citations
17.
Дымова, М. А., et al.. (2016). Molecular Epidemiology of Tuberculosis Infection in Omsk Region. Epidemiology and Vaccinal Prevention. 15(4). 29–36. 1 indexed citations
18.
Kozhamkulov, Ulan, et al.. (2015). Mutations in the <I>pnc</I>A and <I>rps</I>A genes among 77 <I>Mycobacterium tuberculosis</I> isolates in Kazakhstan. The International Journal of Tuberculosis and Lung Disease. 19(2). 179–184. 42 indexed citations
19.
Дымова, М. А., et al.. (2014). Characterization of extensively drug-resistant Mycobacterium tuberculosis isolates circulating in Siberia. BMC Infectious Diseases. 14(1). 478–478. 14 indexed citations
20.
Дымова, М. А., et al.. (2013). Characterization of extensively drug-resistant mycobacterium tuberculosis in Siberia. European Respiratory Journal. 42(Suppl 57). P2821–P2821. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026